NEW YORK (CNNMoney) -- Johnson & Johnson is recalling yet another batch of Tylenol medicines due to consumer complaints about a musty, moldy smell.
Johnson & Johnson's (JNJ, Fortune 500) McNeil division, which makes over-the-counter drugs such as Tylenol, Motrin and Benadryl, said the latest recall includes one lot of Tylenol 8 Hour (150 count) extended release caplets, or 34,000 bottles.
McNeil said the new recall is part of the company's ongoing surveillance of its products.
The company said the Tylenol product involved in this latest recall was manufactured at its Fort Washington, PA plant prior to the closure of that facility in April 2010 following recalls of millions of non-prescription children's drugs made there.
Earlier this month, the government announced it was taking over three Tylenol plants operated by McNeil following the blizzard of drug recalls and a Food and Drug Administration criminal investigation into safety issues at the factories.
McNeil recalled more than 50 million bottles of Tylenol, Motrin and Benadryl products last year after receiving complaints of an unusual moldy, musty odor.
The company said at the time that the smell was caused by trace amounts of a chemical called 2,4,6-tribromoanisole, which is applied to wooden pallets that are used to transport and store packaging materials.
In Tuesday's recall, McNeil said the musty odor was again thought to be caused by the presence of trace amounts of 2,4,6-tribromoanisole and 2,4,6-trichloroanisole.
The company said consumers who purchased products from the latest recalled lot should stop using the product.
Consumers can also contact McNeil Consumer Healthcare, either at www.tylenol.com or by calling 1-888-222-6036 (Monday-Friday 8 a.m. to 8 p.m. Eastern Time) for instructions about receiving a refund or product coupon.
Susan Wojcicki said the rate of new moms leaving Google fell by 50% after the company began offering 18 weeks of paid maternity leave. More
The shale boom has been a blessing to Texas, but tumbling oil prices are casting a shadow over the state. More
With two recent IPOs and a digitally-inclined audience of entrepreneurs, non-traditional financing could finally get its big break. More
Payday lenders are spending millions of dollars in Washington in an attempt to get powerful politicians on their side as a government crackdown on the industry heats up. More